Short-term intra-articular steroids are effective (unclear- long term benefits) - no increase risk for knee replacement with repeat steroid injx #osteoarthritis @rheumnow #acr22 #acrreview https://t.co/MJHXWePF70

Nice summary slide of the recently published 2022 Classification Criteria for GCA and TAK! Avalable free! TAK: https://t.co/0aMVPvKgyE GCA: https://t.co/s1aiFpq3r2 #ACR22 #Vasculitis22 @RheumNow https://t.co/x9ufxi7aco

Medicare will cover #DXA testing for these diagnoses ⁦@RheumNow⁩ #acr22 #acrreview https://t.co/keZg0fxyz9

Dr Scher shares his algorithm Rx for #PsA in clinical practice #acrreview #acr22 ⁦@RheumNow⁩ https://t.co/0xB1KwpfW7

Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years ⁦@RheumNow⁩ #acr22 #acrreview #osteoporosis https://t.co/Xzr6TZIlWN

Drug holidays for #osteoporosis RX but be note fracture risk may increase with these holidays- consider an anabolic agent during these times - Dr Tanner #acr22 ⁦@RheumNow⁩ #acrreview https://t.co/6XbpYD5D1X

Dr Tanner presents the features of AFF👇 It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use. #ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj

Here's a nice slide comparing Sjogren's disease and Sarcoidosis: #ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f

Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data I personally love this strategy; I think Phase 2's are an expensive waste of time Better to go big and answer the question? COI: I participate in SELECT-GCA #ACR22 @RheumNow #Vasculitis22 https://t.co/fSs3xt8baA

QD Clinic - When to Worry About Malignancy and Myositis Which myositis patients should you worry and screen for cancer? https://t.co/bfT0rYNS45 https://t.co/cf59fdxBuC

Tomorrow at 3 pm at #ACR22! Join my session on Difficult to treat RA - How do define it? - What are the patient and synovial characteristics? - How do we study it? @RheumNow https://t.co/43UEJhYvRp